SCHEMBL27561985

SCHEMBL27561985

O=C(O)c1c(S(=O)(=O)O)cc(Br)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.46
HSD17B10 Q99714 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GLA P06280 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
CYP2D6 P10635 1/20 0.42
PRNP P04156 1/20 0.41
FABP4 P15090 2/20 0.41
FABP5 Q01469 1/20 0.41
MCL1 Q07820 4/20 0.40
CYP2C9 P11712 2/20 0.40
MPL P40238 2/20 0.36
CYP3A4 P08684 1/20 0.36
STAT6 P42226 1/20 0.36
HIF1A Q16665 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7202860 0.84 HSD17B10 (0.50) CYP1A2HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL16874351 0.81 CYP2D6 (0.50) CYP1A2HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1940101 0.76 CYP1A2 (0.63) CYP1A2HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL11300699 0.76 MPL (0.45) CYP1A2HSD17B10MEN1KMT2ACYP2D6
SCHEMBL9996096 0.75 PRNP (0.54) CYP1A2HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1039306 0.75 CYP1A2 (0.61) CYP1A2HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL4368303 0.75 MCL1 (0.51) CYP1A2HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL1039309 0.75 CYP1A2 (0.61) CYP1A2HSD17B10ALDH1A1MEN1KMT2A
SCHEMBL9780384 0.74 TTR (0.50) CYP1A2ALDH1A1MEN1KMT2ACYP2C19
SCHEMBL7670398 0.74 MEN1 (0.46) CYP1A2HSD17B10ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1309638-A N-substituted naphthamides as neurokinin receptor antagonists ASTRAZENECA AB (SE) 2001-08-22 CN disclosed